← Search

Data · dataset · 2025

Suzetrigine

Listed in Virginia Open Data Portal

JOURNAVX (suzetrigine) is a prescription oral tablet made by Vertex Pharmaceuticals, containing 50 mg of the active ingredient.

Description

It works as a sodium channel blocker and affects certain liver enzymes. Approved for marketing starting January 30, 2025.

This information was generated using AI and is provided for informational and research purposes only. --- ### 🔗 Related Datasets - Vortioxetine — *HealthData.Gov* ---

Links

Where it is published

Documentation and papers

Catalogue records · 1

Topics

Provenance · 1 source records, 7 field assertions
SourceKeyLast seenRaw
Virginia Open Data Portala3bf234c-f08b-4c29-9816-aed76a5311424 h agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].anzsrc:group:4206mapping · data virginia govvocabulary-mapper@1.0.0keywords['public-health']
concepts[field].local:field:medicine-healthmapping · data virginia govconnector:data_virginia_gov@1.0.0
created_datesource · data virginia govconnector:data_virginia_gov@1.0.0
descriptionsource · data virginia govconnector:data_virginia_gov@1.0.0/notes
publication_datesource · data virginia govconnector:data_virginia_gov@1.0.0
titlesource · data virginia govconnector:data_virginia_gov@1.0.0/title
updated_datesource · data virginia govconnector:data_virginia_gov@1.0.0